Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 24, Issue 6, Pages 669-681
Publisher
Elsevier BV
Online
2023-05-13
DOI
10.1016/s1470-2045(23)00170-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder
- (2022) Kenneth Softness et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial
- (2022) Emma Hall et al. EUROPEAN UROLOGY
- Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study
- (2022) Jasper K W Gerritsen et al. LANCET ONCOLOGY
- Current best practice for bladder cancer: a narrative review of diagnostics and treatments
- (2022) Eva Compérat et al. LANCET
- Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy
- (2021) Alberto Pieretti et al. JOURNAL OF UROLOGY
- Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
- (2021) Ananya Choudhury et al. LANCET ONCOLOGY
- Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
- (2021) Trevor J. Royce et al. Clinical Genitourinary Cancer
- Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis
- (2021) Marina Deuker et al. Clinical Genitourinary Cancer
- Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) Thomas W. Flaig et al. Journal of the National Comprehensive Cancer Network
- Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation
- (2020) April Vassantachart et al. UROLOGY
- Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study
- (2020) James W. F. Catto et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
- (2019) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
- (2018) Dipen J Parekh et al. LANCET
- Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer
- (2018) Stephen B. Williams et al. JAMA Surgery
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
- (2018) Jürgen E. Gschwend et al. EUROPEAN UROLOGY
- Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
- (2018) David T Miyamoto et al. LANCET ONCOLOGY
- Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
- (2018) Trevor J. Royce et al. Clinical Genitourinary Cancer
- Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
- (2017) Nicholas J. Giacalone et al. EUROPEAN UROLOGY
- Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy
- (2017) Ross E. Krasnow et al. EUROPEAN UROLOGY
- Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
- (2017) Girish S. Kulkarni et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer
- (2016) Kimberley S. Mak et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
- (2015) Andrew B Sharabi et al. LANCET ONCOLOGY
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
- (2011) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- Treatments effects from randomized trials and propensity score analyses were similar in similar populations in an example from cardiac surgery
- (2011) O. Kuss et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer
- (2010) Guru Sonpavde et al. JOURNAL OF UROLOGY
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
- (2009) Jason A. Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started